alleviate import duty tax, VAT and penalty burden Baht 17 million.  Net cash flows from financing activities Baht 992 million. Resulted from the Company entered into loan Agreement with Link Capital I

and develop securities business related to investment management; “debt financing” shall include the issuance of debt instruments or conclusion of any transaction that would result in or is in substance

be a potential market in the future. For Medical Devices; There is still intense competition in both domestic and foreign markets. Market leaders use price strategies to gain market share. But the

expenses -0.72 -5.45 -4.73 -87% Net income for period 0.01 28.10 -28.09 -100% Earnings per share (THB) 0.00 0.09 -0.09 -100% H1 2019 H1 2018 YoY change YoY % change Unit: Million Thai Baht (THB) Sales and

shareholders and the share repurchase of the subsidiary. The appropriate of capital structure The debt to equity ratio as at 30 June 2018 was 2.4: 1, increased from the debt-to-equity ratio as at 31 December

at 31 December 2017, which was Baht 2,720 million. The change was due to the net profit for the period, the dividend payment to the shareholders and the share repurchase of the subsidiary. The

before share of profit from associates and NCI 824 940 -12.3 1,487 4,755 -68.7 Share of profit from investments in associates, net - - - - 173 -100.0 NCI (2) (3) 33.3 (5) (15) 66.7 Profit attributable to

-355.1 -5.0% Gross Profit 707.7 1,026.1 -318.4 -31.0% Gross Profit Margin (%) 9.5% 12.6% -3.1% SG&A expenses 459.9 440.4 19.5 4.4% Loss on exchange rate 0.0 35.4 -35.4 -100.0% EBIT before share of profit

/1 1,408.0 1,586.1 178.1 12.6% Share of Profit from Investments in Associates and JVs 220.5 563.4 342.9 155.6% Total Cost 621.7 691.7 70.0 11.3% Gross Profit 686.7 558.2 (128.5) (18.7%) Net Profit 42.6

142 166 9,071 8,016 1,055 13% Total Expenses (8,254) (7,221) (148) (156) (8,402) (7,377) 1,025 14% Share of Profit (Loss) 1,800 2,417 19 12 1,819 2,429 (610) (25%) Profit (Loss) before the effects of